Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Comparative efficacy and safety of rimegepant, ubrogepant, and lasmiditan for acute treatment of migraine: a network meta-analysis

PaperCitations, authors & open-access status

Comparative efficacy and safety of rimegepant, ubrogepant, and lasmiditan for acute treatment of migraine: a network meta-analysis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 30 citations, 2021 year and bronze oa status.

30
Citations
2021
Year
bronze
OA Status

Related on ScholarIQ

Linda Harris
Author
Expert Review of Pharmacoeconomics & Outcomes Research
Journal
Migraine and Headache Studies
Topic
Migraine and Headache Studies
Topic
Traumatic Brain Injury Research
Topic
Traumatic Brain Injury and Neurovascular Disturbances
Topic
470M+ articles · free account